Skip to content

Single Use Sphincterotome V(Distal Wireguided) KD-VC412Q-0215 (REF N5777730)Recalls & reported problems

Olympus Medical Systems Corp. · Single Use Sphincterotome V(Distal Wireguided) · Class 2

All models of Single Use Sphincterotome V(Distal Wireguided) (15)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 04953170399336), received between Apr 13, 2022 and Jul 9, 2024 — classified as 1 injury, 4 malfunctions.

The most frequently reported specific device problem is “Break” (2 reports).

1 other recall cover devices cleared under the same FDA submission (K160241); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break2
  • Adverse Event Without Identified Device or Use Problem1
  • Fracture1
  • Material Split, Cut or Torn1

Patient problems

  • No Clinical Signs, Symptoms or Conditions4
  • Pancreatitis1
  • Unspecified Hepatic or Biliary Problem1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 9, 2024Break; Break

    IT WAS REPORTED THAT THE WIRE OF THE SINGLE USE PRELOADED SPHINCTEROTOME BROKE WHEN ELECTRICITY WAS APPLIED. IT DID NOT FALL OFF. THE ISSUE OCCURRED DURING A THERAPEUTIC ENDOSCOPIC SPHINCTEROTOMY (EST) PROCEDURE. THE PROCEDURE WAS COMPLETED WITH A SIMILAR DEVICE. THERE WERE NO REPORTS OF PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19700848 ↗
  • MalfunctionSep 28, 2023Fracture; Fracture

    A CUSTOMER REPORTED TO OLYMPUS, DURING A THERAPEUTIC ENDOSCOPIC SPHINCTEROTOMY (EST), THE KNIFE WIRE TIP BROKE AT THE TIMING OF OUTPUT. THE PROCEDURE WAS COMPLETED USING A REPLACEMENT DEVICE. THERE WAS NO REPORT OF PATIENT HARM ASSOCIATED WITH THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17840813 ↗
  • MalfunctionAug 24, 2023Material Split, Cut or Torn; Material Split, Cut or Torn

    THE CUSTOMER REPORTED TO OLYMPUS, THE SINGLE USE SPHINCTEROTOME V (DISTAL WIREGUIDED) WAS INSPECTED BEFORE USE AND THE COVERING WAS TORN, EXPOSING THE KNIFE WIRE. THE ISSUE WAS FOUND DURING PROCEDURE, AND THE THERAPEUTIC PROCEDURE (ENDOSCOPIC SPHINCTEROTOMY) WAS COMPLETED WITH A SIMILAR DEVICE. THERE WERE NO REPORTS OF PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17612540 ↗
  • MalfunctionDec 22, 2022Break; Break

    AN OLYMPUS SALES REP REPORTED ON BEHALF OF THE CUSTOMER, THE CUTTING WIRE (SINGLE USE SPHINCTEROTOME V) BROKE DURING A THERAPEUTIC SPHINCTEROTOMY. THE PROCEDURE WAS COMPLETED USING ANOTHER DEVICE. THERE WAS NO REPORT OF PATIENT HARM ASSOCIATED WITH THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16035577 ↗
  • InjuryApr 13, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT IS REPORTED IN THE LITERATURE TITLED DOES THE USE OF LOW OSMOLALITY CONTRAST MEDIUM REDUCE THE FREQUENCY OF POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS: A COMPARATIVE STUDY BETWEEN USE OF LOW AND HIGH OSMOLALITY CONTRAST MEDIA,¿ PATIENTS EXPERIENCED ADVERSE EVENTS AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURES USING OLYMPUS DEVICES. CASE WITH PATIENT IDENTIFIER (B)(6) REPORTS PR-4Q-1. CASE WITH PATIENT IDENTIFIER (B)(6) REPORTS KD-VC412Q-0215. CASE WITH PATIENT IDENTIFIER (B)(6) REPORTS FG-V435P. CASE WITH PATIENT IDENTIFIER (B)(6) REPORTS JF-260V. STUDY AIM: EVALUATE THE USEFUL NESS OF IODIXANOL FOR PREVENTION PEP IN COMPARISON WITH MEGLUMINE AMIDOTRIZOATE. METHOD: TWO HUNDRED AND NINETY-ONE PATIENTS WERE ENROLLED AND DIVIDED INTO THE 2 GROUPS ACCORDING TO THE CONTRAST MEDIUM USED. ONE HUNDRED AND FIFTY-FIVE PATIENTS UNDERWENT ERCP WITH MEGLUMINE AMIDOTRIZOATE, AND 136 PATIENTS UNDERWENT ERCP WITH IODIXANOL. THE PRIMARY OUTCOME OF THIS STUDY WAS THE INCIDENCE OF PEP ASSOCIATED WITH THE USE OF EACH CONTRAST MEDIUM. RESULTS: IN THIS STUDY, COMPARISON OF THE MEGLUMINE AMIDOTRIZOATE TREATMENT AND IODIXANOL TREATMENT GROUPS SHOWED NO SIGN

    Patient problems: Pancreatitis; Unspecified Hepatic or Biliary Problem

    MAUDE report 14102113 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K160241. One submission often covers many models, so check the product and lot details in each record.

  • Z-1282-2026 · Jan 7, 2026 · Open, Classified
    Product Name: Single Use 3-Lumen Sphincterotome V (Distal Wire guided) Model/Catalog Number: KD-VC412Q-0215; Software Version: N/A Product Description: These instruments have been

Other Unit, electrosurgical, endoscopic (with or without accessories) devices

All Unit, electrosurgical, endoscopic (with or without accessories) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page